Patent number: 11179297
Abstract: Metal-containing methacrylates incorporated into polymeric materials with antimicrobial capacity for biomedical applications, and more particularly for dental purposes, are provided. The incorporation of metal-containing methacrylates such as calcium methacrylate, tin methacrylate, copper methacrylate, silver methacrylate, in combination or alone, for potentializing antimicrobial effect of cements, in particular, to biomaterial compositions including metal containing methacrylates, such as calcium, tin, copper, silver, nickel, titanium and iron methacrylates, in the formulation of biomaterials for applications in human health provides advantages, particularly in dentistry, and allows for expressive antimicrobial activity to dental compositions, so as to be useful in dental prosthesis, operative dentistry, orthodontics, pediatric dentistry, implantodontics, and endodontics.
Type:
Grant
Filed:
July 21, 2017
Date of Patent:
November 23, 2021
Assignee:
UNIVERSIDADE FEDERAL DE PELOTAS
Inventors:
Giana da Silveira Lima, Rafael Guerra Lund, Evandro Piva, Adriana Fernandes da Silva, Wellington Luiz de Oliveira da Rosa, Raissa Coi de Araújo, Andressa Goicochea Moreira, Julia Adornes Gallas, Tharsis Christini de Almeida Rossato, Juliana Silva Ribeiro, Alexandra Rubin Cocco, Sonia Luque Peralta
Patent number: 11122807
Abstract: The present invention relates to herbicidal mixture comprising L-glufosinate or its salt and a herbicidal compound II selected from chlorthiamid, dichlobenil, flupoxam, indaziflam, isoxaben, triaziflam, 1-cyclohexyl-5-pentafluorphenyloxy-14-[1,2,4,6]thiatriazin-3-ylamine (CAS 175899-01-1), diflufenzopyr, diflufenzopyr-sodium, naptalam and naptalam-sodium, bromobutide, chlorflurenol, chlorflurenol-methyl, cinmethylin, cumyluron, cyclopyrimorate (CAS 499223-49-3) and its salts and esters, dalapon, dazomet, difenzoquat, difenzoquat-metilsulfate, dimethipin, DSMA, dymron, endothal and its salts, etobenzanid, flurenol, flurenol-butyl, flurprimidol, fosamine, fosamine-ammonium, indanofan, maleic hydrazide, mefluidide, metam, methiozolin (CAS 403640-27-7), methyl azide, methyl bromide, methyl-dymron, methyl iodide, MSMA, oleic acid, oxaziclomefone, pelargonic acid, pyributicarb, quinoclamine, tridiphane; bilanaphos (bialaphos) and bilanaphos-sodium.
Type:
Grant
Filed:
August 2, 2018
Date of Patent:
September 21, 2021
Assignee:
BASF SE
Inventors:
Christian Harald Winter, Markus Gewehr